ADA and combined immunodeficiency syndrome: The first successful therapeutic gene therapy in humans in the early 1990s involved treating two children with severe combined immunodeficiency syndrome (SCID) caused by a genetic defect in the enzyme adenosine deaminase (SCID-ADA) (62).